Drug discovery is slow, expensive, and prone to failure because promising targets and responsive patient groups are difficult to identify early.
R&D Focus
AI-assisted target discovery and drug development
Innovative Solution
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines. Its platform integrates advanced computational approaches and machine learning to discover and pharmacologically target new binding pockets on proteins that make them accessible to small-molecule drug discovery and development.
Investment Funding
Last Funding Stage
Series C
Total Funding Amount
256.M
Last Funding Amount
20.M
Last Funding Date
25-06-2024
Startup Stage
Late Stage Venture
Lead Investors
Deerfield Management, RA Capital Management, DCVC Bio, Deerfield, MPM Capital
Revenue
$1M to $10M
People
Founders
Chris Varma
Daniel Nomura
About
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines. Its platform integrates advanced computational approaches and machine learning to discover and pharmacologically target new binding pockets on proteins that make them accessible to small-molecule drug discovery and development.
Products
Demo Product or Complete Product?
Prototype / pilot stage
Something missing or incorrect on this page? Help us enrich this information
